QNRX
Quoin Pharmaceuticals Ltd - ADR

13,445
Loading...
Loading...
News
all
press releases
Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study Data
The stock closed up 20% on Wednesday, driven by promising patient outcomes and no reported adverse events for its Pediatric Peeling Skin Syndrome (PSS) drug, with further treatment and evaluations planned.
Stocktwits·4mo ago
News Placeholder
More News
News Placeholder
Maxim Group Sticks to Their Buy Rating for Quoin Pharmaceuticals (QNRX)
Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals (QNRX Research Report) yesterday. The company's shares opened tod...
TipRanks Financial Blog·1y ago
News Placeholder
Q4 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript
Related Stocks: NAS:QNRX...
GuruFocus·2y ago
News Placeholder
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical...
Globe Newswire·2y ago
News Placeholder
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a clinical stage specialty pharmaceutical company focused on rare and orphan...
Globe Newswire·2y ago
News Placeholder
Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers
Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers...
SeekingAlpha.com: All News·2y ago
News Placeholder
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a specialty pharmaceutical company focused on rare and orphan diseases, today...
Globe Newswire·2y ago
News Placeholder
Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers
Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers...
SeekingAlpha.com: All News·2y ago
News Placeholder
12 titoli sanitari in movimento, pre-market del 04/03/2024
Titoli in rialzo Il titolo Quoin Pharmaceuticals (NASDAQ:QNRX) salito del 129,59% a 6,36 dollari durante la sessione pre-market di luned . Le azioni di Renalytix (NASDAQ:RNLX) hanno guadagnato il...
Benzinga·2y ago
News Placeholder
12 acciones de salud en movimiento durante la preapertura del 04/03/2024
Acciones al alza Quoin Pharmaceuticals (NASDAQ:QNRX) crecieron un 129,95% para establecerse en los 6,37 d lares durante la sesi n del pre-market del lunes. Ainos (NASDAQ:AIMD) experimentaron un...
Benzinga·2y ago

Latest QNRX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.